EX-99.1 2 f17706exv99w1.htm EXHIBIT 99.1 exv99w1
 

Exhibit 99.1
AMERICAN SHARED HOSPITAL SERVICES
FOURTH QUARTER REVENUE INCREASED 19%
OPERATING INCOME INCREASED TO A NEW RECORD
San Francisco, CA, February 22, 2006 — AMERICAN SHARED HOSPITAL SERVICES (AMEX,PCX:AMS), the leading provider of Gamma Knife® radiosurgery services, today announced financial results for the fourth quarter and 2005, highlighted by a 19% increase in fourth quarter revenue and record operating income.
Fourth Quarter Results
For the three months ended December 31, 2005, revenue increased 19% to $4,650,000 compared to $3,910,000 for the same period last year. Operating income increased for the 20th consecutive quarter to a record $914,000, and pre-tax income increased 9% compared to the prior-year period.
Net income for fourth quarter 2005 increased to $479,000, or $0.09 per diluted share. This compares to net income for fourth quarter 2004 of $386,000, or $0.08 per diluted share. The effective tax rate for the fourth quarter 2005 was 30% compared to 38% for the same period in 2004, primarily reflecting adjustments to the estimated state income tax effective rates.
At December 31, 2005, AMS reported working capital of $2,423,000, cash, cash equivalents and short-term securities of $5,835,000, and long-term securities of $2,797,000. At December 31, 2004, cash, cash equivalents and short-term securities were $9,078,000 and the Company held no long-term securities. Shareholders’ equity increased to $18,320,000 compared to $17,546,000 at December 31, 2004.
2005 Results
For the twelve months ended December 31, 2005, revenue increased 11% to $18,231,000 from $16,389,000 for 2004. Operating income increased 6% to a record $3,471,000 from $3,278,000 for the prior year. Income before income taxes increased 6%, to $2,547,000 from $2,397,000 a year earlier.
Net income for 2005 decreased to $1,767,000, or $0.35 per diluted share, from $1,985,000, or $0.39 per diluted share, for 2004, reflecting primarily a reduction in income tax benefit for 2005 compared to 2004.
Operations Review
“Growth in 2005 was driven by the addition of three new Gamma Knife units to our portfolio during the year, as well as higher same-center treatment volume. Profitability also benefited from our focus on effective cost management at the corporate level and at our 21 Gamma Knife units now in operation,” said Ernest A. Bates, M.D., Chairman and Chief Executive Officer.
“As a leader in the market for Gamma Knife units and other advanced therapeutic equipment, AMS has an outstanding long-term growth opportunity. While we were disappointed that we did not enter into any new contracts in 2005, we continue to work through the sales process with several potential new clients and we are confident that contracts will be awarded to AMS soon. We continue to explore opportunities for Gamma Knife units, the latest Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) equipment and our proprietary Operating Room for the 21st Century concept. We are optimistic about the outlook for 2006,” Dr. Bates added.

 


 

Earnings Conference Call
American Shared has scheduled a conference call at 4:00 pm EDT (1:00 pm PDT) today. To participate in the live call, dial 800-471-6718 at least 5 minutes prior to the scheduled start time. A simultaneous WebCast of the call may be accessed through the Company’s website, www.ashs.com, or through CCBN, www.earnings.com. A replay will be available for 30 days at these same internet addresses, or by calling 888-843-8996, pass code 13832223.
About AMS
American Shared Hospital Services is building a profitable medical services company in an underserved niche — turnkey technology solutions for advanced radiosurgical procedures. The Company’s core business is supplying hospitals with the Gamma Knife — a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Gamma Knife, the gold standard in radiosurgery, reduces surgical risk and patient discomfort, resulting in a shorter hospital stay and lower risk of complications. In most cases, Gamma Knife patients resume their normal activities within a few days of treatment, compared to weeks or months for patients who undergo conventional surgery. More than 250,000 patients worldwide have already received this treatment. American Shared Hospital Services is the world leader in providing Gamma Knife radiosurgery services.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife business and the risks of developing its IMRT and The Operating Room for the 21st Century® programs. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2004, its Quarterly Report on Form 10-Q for the periods ended March 31, 2005, June 30, 2005 and September 30, 2005 and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 16, 2005.
     
Contacts:
  American Shared Hospital Services
 
  Ernest A. Bates, M.D., (415) 788-5300
 
  Chairman and Chief Executive Officer
 
  e.bates@ashs.com
 
   
 
  Berkman Associates
 
  Neil Berkman, Ph.D., (310) 826-5051
 
  President
 
  info@berkmanassociates.com

 


 

AMERICAN SHARED HOSPITAL SERVICES
PRESS RELEASE
Fourth Quarter 2005 Financial Results
  February 22, 2006
Page 3
                                       
            Summary of Operations Data          
 
                               
    Three months ended December 31,     Twelve months ended December 31,  
 
                               
    2005     2004     2005     2004  
Revenue
  $ 4,650,000     $ 3,910,000     $ 18,231,000     $ 16,389,000  
Costs of revenue
    2,273,000       1,951,000       9,072,000       7,887,000  
 
                       
Gross margin
    2,377,000       1,959,000       9,159,000       8,502,000  
Selling & administrative expense
    965,000       618,000       3,613,000       2,963,000  
Interest expense
    498,000       534,000       2,075,000       2,261,000  
 
                       
Operating income
    914,000       807,000       3,471,000       3,278,000  
Interest & other income
    73,000       38,000       202,000       102,000  
Minority interest expense
    (302,000 )     (219,000 )     (1,126,000 )     (983,000 )
 
                       
Income before income taxes
    685,000       626,000       2,547,000       2,397,000  
Income tax expense
    206,000       240,000       780,000       412,000  
 
                       
Net income
  $ 479,000     $ 386,000     $ 1,767,000     $ 1,985,000  
 
                       
 
                               
Earnings per common share:
                               
Basic
  $ 0.10     $ 0.08     $ 0.36     $ 0.46  
 
                       
Assuming dilution
  $ 0.09     $ 0.08     $ 0.35     $ 0.39  
 
                       
 
                               
    Balance Sheet Data                
 
                               
 
    12/31/2005       12/31/2004                  
 
                           
Cash and cash equivalents
  $ 1,298,000     $ 8,121,000                  
Securities-current maturities
  $ 4,537,000     $ 957,000                  
Current assets
  $ 10,709,000     $ 12,672,000                  
Securities-long term
  $ 2,797,000     $ 0                  
Total assets
  $ 48,668,000     $ 47,106,000                  
 
                               
Current liabilities
  $ 8,286,000     $ 7,955,000                  
Shareholders’ equity
  $ 18,320,000     $ 17,546,000